Remyelination Trials: Are We Expecting the Unexpected?

Alexandr Klistorner1, Michael Barnett2

  • 1From the Sydney University (A.K., M.B.); Maquarie University (A.K.); and Sydney Neuroimaging Analysis Center (M.B.), Australia. sasha@eye.usyd.edu.au.

Summary

Remyelination shows promise for multiple sclerosis (MS) neuroprotection. This review examines challenges in remyelination trials, offering design guidance and managing expectations for researchers and industry.

Related Concept Videos